Plant Advanced Technologies SA (EPA:ALPAT)
4.400
-0.500 (-10.20%)
Aug 3, 2026, 3:54 PM CET
EPA:ALPAT Market Cap
EPA:ALPAT has a market cap or net worth of €5.51 million as of August 3, 2026. Its market cap has decreased by -46.41% in one year.
Market Cap
5.51M
Enterprise Value
9.43M
Revenue
1.65M
Ranking
n/a
PE Ratio
9.61
Stock Price
€4.40
ChartMarket Cap Chart
Since August 5, 2009, EPA:ALPAT's market cap has decreased from 6.22M to 5.51M, a decrease of -11.45%. That is a compound annual growth rate of -0.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 5.51M | -40.12% |
| Dec 31, 2025 | 9.20M | -30.22% |
| Dec 31, 2024 | 13.18M | 43.55% |
| Dec 29, 2023 | 9.18M | -36.37% |
| Dec 30, 2022 | 14.43M | -28.63% |
| Dec 31, 2021 | 20.23M | -10.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advicenne | 23.86M |
| genOway Société anonyme | 22.50M |
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| Poxel | 11.26M |
| NFL Biosciences | 11.02M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |